Psychiatry AdvisorGrowing Evidence Supports the Link Between Cannabis Use and Psychosis Risk

Cannabis Use in Adolescence Linked to Significantly Higher Psychosis Risk, Highlighting Potential Developmental Vulnerability

A recent longitudinal study published in Psychological Medicine reveals a strong association between cannabis use and psychotic disorder risk, particularly among adolescents. The research, conducted in Ontario, Canada, utilized population-based survey data and health records to examine the relationship between cannabis consumption and subsequent psychotic disorders in individuals aged 12 to 24 years. The findings bring to light the age-specific considerations in cannabis-related health risks and suggest a need for targeted prevention strategies.

Key Points:

• Study design: Observational longitudinal study using Canadian Community Health Survey data linked with health records from the Institute for Clinical Evaluative Sciences
• Population: 11,363 Ontario residents aged 12-24 years at survey completion (2009-2012)
• Follow-up period: Up to 2018
• Primary outcomes: Time to first outpatient physician visit, emergency department visit, or hospital discharge related to psychotic disorders
• Cannabis use prevalence: 23.4% (n=2,659) reported past-year use
• Psychotic disorder incidence: 1.2% of respondents utilized health services for psychotic disorders during follow-up
• Key finding for adolescents: Cannabis use associated with 11.2 times greater risk for psychotic disorders (aHR, 11.2; 95% CI, 4.6 to 27.3)
• Key finding for young adults: No significant association found (aHR, 1.3; 95% CI, 0.6 to 2.6)
• Hospitalization and emergency department visits for adolescents: 26.7 times higher risk for cannabis users (aHR, 26.7; 95% CI, 7.7 to 92.8)
• Hospitalization and emergency department visits for young adults: No substantial risk observed (aHR, 1.8; 95% CI, 0.6 to 5.4)
• Proportion of adolescent psychotic disorder cases with cannabis use: 77.8% reported past-year use, 82.3% reported lifetime use
• Study limitations: Reliance on self-reported data during cannabis prohibition may have led to underreporting; observational design limits causal inferences

HCN Medical Memo
This study emphasizes the critical importance of age-specific considerations in cannabis-related health risks. The significantly higher risk of psychotic disorders among adolescent cannabis users, compared to young adults, suggests a potential developmental vulnerability. Healthcare providers should prioritize evidence-based prevention strategies and education for adolescents regarding cannabis use, while remaining vigilant for early signs of psychosis in young cannabis users.

More on Cannabis/Marijuana